2021 MiECTiS focused update on the 2016 position paper for the use of minimal invasive extracorporeal circulation in cardiac surgery.

Autor: Anastasiadis, Kyriakos, Antonitsis, Polychronis, Murkin, John, Serrick, Cyril, Gunaydin, Serdar, El-Essawi, Aschraf, Bennett, Mark, Erdoes, Gabor, Liebold, Andreas, Punjabi, Prakash, Theodoropoulos, Konstantinos C, Kiaii, Bob, Wahba, Alexander, de Somer, Filip, Bauer, Adrian, Kadner, Alexander, van Boven, Wim, Argiriadou, Helena, Deliopoulos, Apostolos, Baker, Robert Α
Předmět:
Zdroj: Perfusion; Oct2023, Vol. 38 Issue 7, p1360-1383, 24p
Abstrakt: The landmark 2016 Minimal Invasive Extracorporeal Technologies International Society (MiECTiS) position paper promoted the creation of a common language between cardiac surgeons, anesthesiologists and perfusionists which led to the development of a stable framework that paved the way for the advancement of minimal invasive perfusion and related technologies. The current expert consensus document offers an update in areas for which new evidence has emerged. In the light of published literature, modular minimal invasive extracorporeal circulation (MiECC) has been established as a safe and effective perfusion technique that increases biocompatibility and ultimately ensures perfusion safety in all adult cardiac surgical procedures, including re-operations, aortic arch and emergency surgery. Moreover, it was recognized that incorporation of MiECC strategies advances minimal invasive cardiac surgery (MICS) by combining reduced surgical trauma with minimal physiologic derangements. Minimal Invasive Extracorporeal Technologies International Society considers MiECC as a physiologically-based multidisciplinary strategy for performing cardiac surgery that is associated with significant evidence-based clinical benefit that has accrued over the years. Widespread adoption of this technology is thus strongly advocated to obtain additional healthcare benefit while advancing patient care. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index